World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
57405
World Ranking
3724
National Ranking
2053

Charles E. Alpers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles E. Alpers sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 476 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles E. Alpers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles E. Alpers sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 120 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1998 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Charles E. Alpers is affiliated with the University of Washington in the United States. Their research primarily focuses on medicine, with a substantial emphasis on nephrology, immunology, pulmonary and respiratory medicine, molecular biology, and genetics.

The scientist's work covers a range of topics, including:

  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Single-cell and spatial transcriptomics
  • Systemic Lupus Erythematosus Research
  • Diabetes Treatment and Management
  • Renal and Vascular Pathologies
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema

Frequent publication venues for Charles E. Alpers include:

  • Journal of the American Society of Nephrology
  • Kidney International
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Kidney Diseases
  • Kidney International Reports

Coauthors with whom Charles E. Alpers has frequently collaborated include:

  • Laura Barisoni
  • Shreeram Akilesh
  • Roberto F. Nicosia
  • Jonathan Barratt
  • Kelly D. Smith

Some of their recent papers are:

  • Molecular mechanisms and therapeutic targets for diabetic kidney disease (2022), Kidney International
  • Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023), The Lancet
  • Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023), The Lancet
  • Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria (2020), American Journal of Kidney Diseases
  • Rationale and design of the Kidney Precision Medicine Project (2021), Kidney International

Charles E. Alpers has been recognized with the award of Fellow of the American Association for the Advancement of Science (AAAS) in 1998.

Best Publications

  • The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

    Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan

  • VEGF inhibition and renal thrombotic microangiopathy.

    Vera Eremina;J. Ashley Jefferson;Jolanta Kowalewska;Howard Hochster

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

    Richard J. Johnson;David R. Gretch;Hideaki Yamabe;Jaime Hart

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Hernán Trimarchi;Jonathan Barratt;Daniel C. Cattran;H. Terence Cook

  • Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

    Cecilia M. Giachelli;Nancy Bae;Manuela Almeida;David T. Denhardt

  • Mouse Models of Diabetic Nephropathy

    Frank C. Brosius;Charles E. Alpers;Erwin P. Bottinger;Matthew D. Breyer

  • Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content

    Kevin D. O’Brien;Thomas O. McDonald;Alan Chait;Margaret D. Allen

  • Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices

    Ingeborg M. Bajema;Suzanne Wilhelmus;Charles E. Alpers;Jan A. Bruijn

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis

    Kevin D. O’Brien;Dennis D. Reichenbach;Santica M. Marcovina;Johanna Kuusisto

  • Renal injury from angiotensin II-mediated hypertension.

    Richard J. Johnson;Charles E. Alpers;Ashio Yoshimura;Donna Lombardi

  • Autopsy findings in the acquired immune deficiency syndrome.

    Kevin Welch;Walter Finkbeiner;Charles E. Alpers;Walter Blumenfeld

  • Osteopontin Is Expressed in Human Aortic Valvular Lesions

    Kevin D. O’Brien;Johanna Kuusisto;Dennis D. Reichenbach;Marina Ferguson

  • Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis

    Seppo T. Nikkari;Kevin D. O’Brien;Marina Ferguson;Thomas Hatsukami

  • Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.

    R J Johnson;H Iida;C E Alpers;M W Majesky

  • Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model

    Jürgen Floege;Mark W. Burns;Charles E. Alpers;Ashio Yoshimura

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Agnes B. Fogo
Agnes B. Fogo Vanderbilt University Medical Center
Richard J. Johnson
Richard J. Johnson University of Colorado Denver
William G. Couser
William G. Couser University of Washington
Stuart J. Shankland
Stuart J. Shankland University of Washington
Jürgen Floege
Jürgen Floege RWTH Aachen University
Kelly D. Smith
Kelly D. Smith University of Washington
J. Charles Jennette
J. Charles Jennette University of North Carolina at Chapel Hill
Vivette D. D'Agati
Vivette D. D'Agati Columbia University
Kevin D. O'Brien
Kevin D. O'Brien University of Washington
Cecilia M. Giachelli
Cecilia M. Giachelli University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine doesn't always mean a traditional path. Many online programs now offer flexibility for aspiring healthcare professionals to advance their education and career. If you’re interested in a swift route to upper-level nursing roles, options like accelerated dnp programs allow you to earn a Doctor of Nursing Practice in less time.

For those looking for the shortest dnp program, several universities now offer condensed curricula designed for working nurses seeking advanced clinical expertise. If you're starting out, fast track lpn programs online can help you quickly enter the workforce as a Licensed Practical Nurse, with flexible study schedules.

Nurses with a master's degree can pursue specialized practice even faster through the shortest post master's pmhnp online programs, becoming psychiatric-mental health nurse practitioners in record time. With these online pathways, you can tailor your medical career to your goals and timelines, making advanced healthcare roles more accessible than ever before.

Best Scientists Citing Charles E. Alpers

Trending Scientists

Recently Published Articles